Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL0600064	重组人CD22单克隆抗体注射液	Recombinant anti-CD22 humanized monoclonal antibody	Injection	Biological Products(2)	New Drug Application	2007-01-22	深圳龙瑞药业有限公司	Lonn Ryonn PHARMA Ltd	Certificate Issued	2008-03-24	view
CXSL0600048	重组人CD22单克隆抗体注射液	Recombinant anti-CD22 humanized monoclonal antibody	Injection	Biological Products(2)	New Drug Application	2006-10-23	深圳龙瑞药业有限公司	Lonn Ryonn PHARMA Ltd	Certificate Issued	2008-12-22	view
CXSL0500026	重组人CD22单克隆抗体注射液	Recombinant anti-CD22 humanized monoclonal antibody	Injection	Biological Products(2)	New Drug Application	2005-04-01	深圳龙瑞药业有限公司	Lonn Ryonn PHARMA Ltd	Certificate Issued	2006-08-24	view
CXSL0500025	重组人CD22单克隆抗体注射液	Recombinant anti-CD22 humanized monoclonal antibody	Injection	Biological Products(2)	New Drug Application	2005-04-01	深圳龙瑞药业有限公司	Lonn Ryonn PHARMA Ltd	Certificate Issued	2006-08-24	view
CXSB0900032	重组人CD22单克隆抗体注射液	Recombinant anti-CD22 humanized monoclonal antibody	Injection	Biological Products	Supplementary Application	2010-01-08	深圳龙瑞药业有限公司	Lonn Ryonn PHARMA Ltd	Certificate Issued	2010-11-23	view